Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

SuiRWA is training its investment AI agents on extensive data, using neural networks for pattern recognition. They learn via supervised & unsupervised methods, with fine-tuning for market analysis, ensuring accuracy and minimizing bias. A revolution in investing might be here.

16,168 Aufrufe • vor 1 Jahr •via X (Twitter)

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

EFSANE is a global, comprehensive investment and fintech platform focused on two core areas: stocks and cryptocurrencies. We are committed to creating a one-stop investment ecosystem for users, integrating information, strategies, education, trading, and community. Since its founding, EFSANE has been committed to "making investing simpler and wealth management more scientific," providing professional market analysis, investment education, and asset allocation guidance to over 10 million users worldwide. The platform's core advantages include: 1. Diversified Investment Ecosystem: Covering multiple modules including stocks, cryptocurrencies, prediction markets, blockchain games, live streaming, and social interaction, users can learn, communicate, and practice on a single platform. 2. Professional Investment Research: Led by the EFSANE team, our investment research team utilizes quantitative models and macroeconomic analysis to provide accurate market judgment and trading strategies. 3. Secure and Transparent Operational Mechanism: EFSANE maintains a comprehensive risk control system and a multi-faceted compliance framework to ensure the security of user funds and data. 4. Global Presence: Headquartered in Singapore, with regional operations centers in Dubai, New York, and Hong Kong, EFSANE serves over 30 countries and regions. As the global financial landscape evolves, EFSANE is actively promoting the integration of stock tokenization and crypto investment education, building a bridge to the new era of Web3 finance for global investors. 🌐❤️ New users joining EFSANE can receive free EFS tokens (worth $6): 📲Join EFSANE and embark on a new journey of smart investing.

EFSANE

33,930 Aufrufe • vor 10 Monaten

Biomni Lab lets biologists collaborate with AI agents to finish complex tasks end-to-end. Here are 15 popular use cases, each link is a full replay so you can watch the agent work through every step: 1. Spatial transcriptomics analysis: map gene expression across tissue architecture from spatial transcriptomics data, with spatial clustering and neighborhood analysis. 2. Binder design: design de novo protein binders against a target structure using computational protein design tools. 3. Biomarker panel design: identify and optimize a multi-marker diagnostic or prognostic panel from omics data. 4. Clinical trial landscaping: search and summarize the trial landscape for a disease area, mapping phase, endpoints, and sponsor activity. 5. Survival analysis: pull clinical and expression data, fit Cox models, generate Kaplan-Meier curves, and identify prognostic markers. 6. scRNA-seq processing and annotation: from raw counts to UMAP clustering, marker gene detection, and automated cell type labeling. 7. Cell-cell communication: infer ligand-receptor interactions between cell types from single-cell data and map intercellular signaling networks. 8. Primer design for novel Cas13: analyze a putative Cas13 protein from a metagenomic screen—verify the ORF, identify HEPN domains, and design cloning primers with restriction sites and a FLAG 9. Proteomics differential expression: normalize mass spec data, run statistical tests, and visualize differentially abundant proteins. 10. Gene regulatory network inference: reconstruct transcription factor-target gene networks from expression data and identify key regulators. 11. Gene co-expression network analysis: build weighted co-expression networks, identify gene modules, and correlate them with phenotypic traits. 12. Microbiome analysis: process 16S/metagenomic sequencing data to profile microbial communities, diversity, and differential abundance. 13. Polygenic risk scores: compute and evaluate PRS from GWAS summary statistics against a target cohort. 14. Variant annotation: annotate genetic variants with functional predictions, allele frequencies, and clinical significance. 15. Fine-mapping: narrow GWAS loci to credible causal variants using statistical fine-mapping methods. Each of these would normally take days to weeks of scripting, debugging, and iteration. In Biomni Lab, the agent handles the full execution while you steer the science. Learn more:

Kexin Huang

27,635 Aufrufe • vor 4 Monaten